Catalyst Wire Dossier Catalyst Wire Dossier

CJ Imatinib Mesylate Tablet 200mg x1

imatinib mesylate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CJ Imatinib Mesylate Tablet 200mg x1, covering 2013-08-21 to 2013-08-21. Get the full timeline:

Most recent: Clinical Trial Update: to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers [Phase 1]

See pricing